| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.38 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.29 | 0.08 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.27 | 0.05 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.24 | 0.08 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.23 | 0.4 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.18 | 0.4 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.15 | 0.01 |